GLPwatch
Trials (2139)
Page 11 of 36.
- GLP Analogs for Diabetes in Wolfram Syndrome Patients
- Tirzepatide in Idiopathic Intracranial Hypertension Trial
- A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
- Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
- A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
- Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
- A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity
- Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?
- Effect of Semaglutide in Patients With Psoriasis and Obesity
- Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
- Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
- The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity
- Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
- Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment
- A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes
- Impact GLP-1 Agonists Following Bariatric
- A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
- Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
- Bariatric Surgery vs. Semaglutide vs. Tirzepatide
- Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation
- Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients
- Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes
- Semaglutide and Vascular Regeneration
- Spartina® (Tirzepatide) Effectiveness and Safety Evaluation
- Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
- Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus
- Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
- Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)
- Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
- Impact of Liraglutide 3.0 on Body Fat Distribution
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Impact of Semaglutide on CD34+ EPC and Fat Derived MSC
- LIROH - Liraglutide for Obesity in HIV
- Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)
- A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)
- Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus
- A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
- Efficacy of Liraglutide Therapy in Patients With IPAA
- Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity
- HbA1c Variability in Type II Diabetes
- A Study on How NNC0174-1213 Works in People With Overweight or Obesity.
- A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice
- Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes
- Incretin-based Drugs and Pancreatic Cancer
- A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.
- Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
- A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
- The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
- Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)
- Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study
- Special Use - Results Surveillance on Long-term Use With Wegovy®
- Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity
- Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
- The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients
- Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
- High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE)
- GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation